Please login to the form below

Not currently logged in
Email:
Password:

Alzheimer

This page shows the latest Alzheimer news and features for those working in and with pharma, biotech and healthcare.

GW Pharma's cannabis-based medicine to be tested in dementia

GW Pharma's cannabis-based medicine to be tested in dementia

Trial will be funded by Alzheimer’s Research UK. Alzheimer’s Research UK is to sponsor a clinical trial of GW Pharmaceuticals’ Sativex to treat agitation and aggression in people with ... Now the oral spray will now undergo testing to examine

Latest news

  • Alector kicks off next wave of biotech IPOs Alector kicks off next wave of biotech IPOs

    overcome disappointments seen in neurology, most especially in Alzheimer’s disease. ... Its initial focus is on frontotemporal dementia (AL001 entering phase 1 trials in September) and Alzheimer’s disease, AL002 also entering phase 1 in December.

  • J&J bolsters gene therapy unit with $100m MeiraGTx deal J&J bolsters gene therapy unit with $100m MeiraGTx deal

    J&J’s earlier forays into this area include a collaboration with the University of Pennsylvania on an Alzheimer’s programme, announced in early 2018.

  • Ocrevus helps Roche shrug off biosimilars in 2018 Ocrevus helps Roche shrug off biosimilars in 2018

    Good news after Alzheimer's failure. Roche saw a decline in its European sales last year as biosimilars started to bite its blockbuster biologic drugs, but strong growth for new products ... The buoyant performance will help numb the pain of Roche’s

  • Another amyloid bust as Roche pulls crenezumab trials Another amyloid bust as Roche pulls crenezumab trials

    Undermines amyloid hypothesis hopes. including Biogen candidate. Roche has halted a pair of phase 3 trials for its amyloid-targeting antibody crenezumab in Alzheimer’s disease (AD) after an interim look ... It’s not the end of the story for the drug

  • Researchers reverse Alzheimer’s memory loss in mice Researchers reverse Alzheimer’s memory loss in mice

    The Buffalo researchers believe their work in the developing science of epigenetics will yield answers in the elusive search for new Alzheimer's therapies. ... Meanwhile, the next big hope in the pharma industry’s late stage pipeline for Alzheimer’s

More from news
Approximately 92 fully matching, plus 379 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 3 fully matching, plus 38 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 23 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 3 fully matching, plus 17 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Grace Communications

Grace Communications is an award winning, independent, full service, creative communications agency specialising in solving problems for healthcare brands....

Latest intelligence

The importance of co-creation with patients
Overcoming the barriers...
Three billboards on the road to multichannel
Chris Ross examines the trends driving multichannel communication in 2019...
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics